Other – Targovax

February 1, 2022

Press release - Non-regulatory

Targovax inngår forskningssamarbeid med Karolinska Institutet (Norwegian)

IR contact

Dr Lubor Gaal

Chief Financial Officer

lubor.gaal@targovax.com

(+34) 683 343 811

Renate Birkeli

Investor Relations

renate.birkeli@targovax.com

+47 922 61 624

Q1 First Quarter 2022

Targovax ASA (OSE: TRVX) published its first quarter 2022 results on Thursday 12 May 2022.

Read the report

This website uses cookies to ensure you get the best experience on our website. Learn More | Terms of Use

Yes, I accept